These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 6201059)

  • 1. Surface antigens of stocks and clones of Trypanosoma cruzi isolated from humans.
    Zingales B; Abuin G; Romanha AJ; Chiari E; Colli W
    Acta Trop; 1984 Mar; 41(1):5-16. PubMed ID: 6201059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cryptic epitope explains the failure of a monoclonal antibody to bind to certain isolates of Trypanosoma cruzi.
    Kirchhoff LV; Hieny S; Shiver GM; Snary D; Sher A
    J Immunol; 1984 Nov; 133(5):2731-5. PubMed ID: 6207242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological characterization of Trypanosoma cruzi stocks from Chilean insect vectors.
    Solari A; Wallace A; Ortiz S; Venegas J; Sanchez G
    Exp Parasitol; 1998 Jul; 89(3):312-22. PubMed ID: 9676709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative differences in the expression of a 72,000 molecular weight cell surface glycoprotein (GP72) in Trypanosoma cruzi zymodemes.
    Chapman MD; Snary D; Miles MA
    J Immunol; 1984 Jun; 132(6):3149-53. PubMed ID: 6427332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in isotype composition and antigen recognition of anti-Trypanosoma cruzi antibodies from acute to chronic Chagas disease.
    Umezawa ES; Shikanai-Yasuda MA; Stolf AM
    J Clin Lab Anal; 1996; 10(6):407-13. PubMed ID: 8951611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [SDS-PAGE analysis of surface proteins and antigens evidences high heterogenity in natural clones of Trypanosoma cruzi, correlated with isoenzyme variability].
    Brenière SF; Araniki I; Le Ray D; Tibayrenc M
    C R Acad Sci III; 1991; 312(9):449-54. PubMed ID: 1905971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloning and partial characterization of a 28 kDa antigenic protein of Trypanosoma cruzi.
    Abate T; Rosenberg M; Aldao RR; Slezynger TC
    Biol Res; 1993; 26(1-2):121-30. PubMed ID: 7670524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trypanosoma cruzi: characterization and isolation of a 57/51,000 m.w. surface glycoprotein (GP57/51) expressed by epimastigotes and bloodstream trypomastigotes.
    Scharfstein J; Schechter M; Senna M; Peralta JM; Mendonça-Previato L; Miles MA
    J Immunol; 1986 Aug; 137(4):1336-41. PubMed ID: 3090146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amastigote and epimastigote stage-specific components of Trypanosoma cruzi characterized by using monoclonal antibodies. Purification and molecular characterization of an 83-kilodalton amastigote protein.
    Pan AA; McMahon-Pratt D
    J Immunol; 1989 Aug; 143(3):1001-8. PubMed ID: 2501384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trypanosoma cruzi: characterization of two recombinant antigens with potential application in the diagnosis of Chagas' disease.
    Gruber A; Zingales B
    Exp Parasitol; 1993 Feb; 76(1):1-12. PubMed ID: 8467895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunology of Chagas' disease. III--Absorption of human chagasic sera with epimastigotes of different strains of Trypanosoma cruzi.
    Araujo FG; Nunes RM
    Rev Inst Med Trop Sao Paulo; 1978; 20(6):315-7. PubMed ID: 108797
    [No Abstract]   [Full Text] [Related]  

  • 12. A Mr 90 000 surface polypeptide of Trypanosoma cruzi as a candidate for a Chagas' disease diagnostic antigen.
    Dragon EA; Brothers VM; Wrightsman RA; Manning J
    Mol Biochem Parasitol; 1985 Sep; 16(3):213-29. PubMed ID: 3932849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of antibody cross-reactivity in experimental American trypanosomiasis.
    Rosfjord EC; Mikhail KS; Rowland EC; Powell MR
    J Parasitol; 1990 Oct; 76(5):698-702. PubMed ID: 1698959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoblot analysis of trypomastigote excreted-secreted antigens as a tool for the characterization of Trypanosoma cruzi strains and isolates.
    Kesper N; de Almeida KA; Stolf AM; Umezawa ES
    J Parasitol; 2000 Aug; 86(4):862-7. PubMed ID: 10958475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic polymorphism of Trypanosoma cruzi: clonal analysis of trypomastigote surface antigens.
    Plata F; Garcia Pons F; Eisen H
    Eur J Immunol; 1984 May; 14(5):392-9. PubMed ID: 6373305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of cross-reactivity of lytic antibodies with bloodstream forms of Trypanosoma cruzi zymodemes generated in a mouse experimental model.
    Wallace A; Sanchez G; Venegas J; Solari A
    Exp Parasitol; 1995 Mar; 80(2):176-85. PubMed ID: 7895829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of Trypanosoma cruzi, T. cruzi marinkellei, T. dionisii and T. vespertilionis by monoclonal antibodies.
    Petry K; Baltz T; Schottelius J
    Acta Trop; 1986 Mar; 43(1):5-13. PubMed ID: 2424290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular approaches to diagnosis of Chagas' disease: use of defined antigens and a target ribosomal RNA sequence.
    Zingales B; Golgher DB; Marmorato PG; Souto RP; Gruber A
    Biol Res; 1993; 26(1-2):89-100. PubMed ID: 7670551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trypanosoma rangeli: epimastigote immunogenicity and cross-reaction with Trypanosoma cruzi.
    Saldaña A; Sousa OE
    J Parasitol; 1996 Apr; 82(2):363-6. PubMed ID: 8604121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of major surface and excretory-secretory immunogens of Trypanosoma cruzi trypomastigotes and identification of potential protective antigen.
    Ouaissi MA; Taibi A; Cornette J; Velge P; Marty B; Loyens M; Esteva M; Rizvi FS; Capron A
    Parasitology; 1990 Feb; 100 Pt 1():115-24. PubMed ID: 2107503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.